Role of -55CT polymorphism of UCP3 gene on non alcoholic fatty liver disease and insulin resistance in patients with obesity

Nutricion Hospitalaria

Volumn 25, Issue 4, 2010, Pages 572-576

  Aller, R ^a   De Luis, D A ^b   Izaola, O ^b   Gonzalez Sagrado M ^b   Conde, R ^b   Alvarez, T ^a   Pacheco, D ^b   Velasco, M C ^b  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^b UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

55CT polymorphism of UCP3 gene; Biopsy; Insulin resistance; Obesity; Steatosis

Indexed keywords

ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 3;

ADULT; ARTICLE; FATTY LIVER; FEMALE; GENETIC POLYMORPHISM; GENETICS; HUMAN; INSULIN RESISTANCE; MALE; OBESITY;

ADULT; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; ION CHANNELS; MALE; MITOCHONDRIAL PROTEINS; OBESITY; POLYMORPHISM, GENETIC;

EID: 77954808440     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.4.4484     Document Type: Article

References (33)

1. Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clinic Proc 1980; 55: 434-438
2. Kral JG, Schaffner F, Pierson RN, Wang J: Body fat topography as an independent predictor of fatty liver. Metabolism 1993; 42: 548-551
3. Aller R, de Luis DA, Fernadez L, Caller F, Velayos B, Olcoz JL, Izaola O, Gonzalez Sagrado M, Conde R, Gonzalez JM. Influence of insulin resistance and adipokines in the grade of steatosis of non-alcoholic fatty liver disease. Dig Dis Sci 2008; 53: 1088-1092
4. Marceau P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, Kral JG: Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 1999; 84: 1513-1517
5. Hui JM, Hodge A, Farrell GC, Kench JG, Kriketos A, George J. Beyond insulin resistance in NASH: TNF-alpha or adiponectin? Hepatology 2004; 40: 46-54.
6. Newberry EP, Xie Y, Kennedy SM, Luo J, Davidson NO. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 2006: 44: 1191-1205
7. Bouchard C, Perusse L, Chagnon YC, Warden C, Ricquier D. Linkage between markers in the vicinity of uncoupling protein 2 gene and resisting metabolic rate in humans. Hum Mol Gent 1997; 6: 1887-1889
8. Clapham J, Arch J, Chapman H et al. Mice over expressing human uncoupling protein 3 in skeletal muscle are hyperphagic lean. Nature 2000; 406: 415-418
9. Samec S, Seydoux J, Dullo A. Role of UCP homologues in skeletal muscles and brown adipose tissue: mediators of thermogenesis or regulators of lipids as fuel substrate? FASEB J 1998; 12: 715-724
10. De Luis DA, Aller R, Izaola O, González Sagrado M, Conde R. Modulation of insulin concentrations and metabolic parameters in obese patients by -55CT polymorphism of the UCP3 gene secondary to two hypocaloric diets. Horm Metab Res 2009; 41: 62-66
11. De Luis DA, González Sagrado M, Conde R, Aller R, Izaola O. Lack of association of -55ct polymorphism of UCP3 gene with fat distribution in obese patients. Ann Nutr Metab 2007; 51: 374-378
12. Schrauwen P, Xia J, Walder K, Snitker S, Ravussin E. A novel polymorphism in the proximal UCP3 promoter region: effect on skeletal muscle. UCP3 m RNA expression and obesity in male non-diabetic Pima Indians. Int J Obes 1999; 23: 1242-1245
13. Otabe S, Clement K, Dina C et al. A genetic variation in the 5'flanking region of the UCP3 is associated with body mass index in humans in interaction with physical activity. Diabetologia 2000: 43: 245-249
14. Meirhaeghe A, Amouyel P, Helbecque N et al. An uncoupling protein 3 gene polymorphism associated with a lower risk of developing type 2 diabetes and with atherogenic lipid profile in a French cohort. Diabetologia 2000: 43: 1424-1428
15. Alonso A, Marti A, Corbalan MS, Martínez González MA, Forga L, Martínez JA. Association of UCP3 gene -55CT polymorphism and obesity in a Spanish population. Ann Nutr Metab 2005; 49: 183-188
16. Brunt EM. Nonalcoholic steatohepatitis: definition and pathology. Semin Liver Dis 2001; 21: 3-16.
17. Duart MJ, Arroyo CO, Moreno JL. Validation of a insulin model for the reactions in RIA. Clin Chem Lab Med 2002; 40: 1161-1167
18. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Pedersen O. Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-414
19. Pfutzner A, Langefeld M, Kunt T, Lobig M. Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin lab 2003; 49: 571-576
20. Meier U, Gressner M. Endocrine regulation of energy metabolis: review of pathobiochemical and clinical chemical aspects of leptin, Ghrelin, adiponectin, and resistin. Clinical Chemistry 2004; 50: 1511-1525
21. Suominen P. evaluation of an enzyme immunometric assay to measure serum adiponectin concentrations. Clin Chem 2004; 50: 219-221
22. Lubrano V, Cocci F, Battaglia D, Papa A. Usefulness of high -sensitivity IL6 measurmentbfor clinical characterization of patients with coronary artery disease. J Clin Lab Anal 2005; 19: 110-114
23. Khan SS, Smith MS, reda D, Suffredini AF, Mc Coy JP. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufactures. Cytometry B Clin Cytom 2004; 61: 35-39
24. Hesselink MKC, Mensink M, Schrauwen. Human uncoupling protein-3 and obesity. Obesity Research 2003; 11; 1429-1440
25. Dalgaard LT, Sorensen TIA, Drivshom T, Borch Johnsen K, Andersen T, Hansen T. A prevalent polymorphism in the promoter of the UCP3 gene and its relationship to body mass index and long term body weight change in the Danish population. J Clin Endoc Metab 2001; 86: 1398-1402
26. Liu YJ, Liu PY, Long J, Lu Y, Elze L, Recker RR, Deng HW. Linkage and association analyses of the UCP3 gene with obesity phenotypes in Caucasian families. Physiol Genomics 2005; 22: 197-203.
27. Cassell PG, Saker PJ, Huxtable SJ, Kousta E, Jackson AE, Hattersle AT. Evidence that single nucleotide polymorphism in the uncoupling protein 3 gene influences fat distribution in women of European and Asian origin. Diabetologia 2000; 43: 1558-1564
28. Marchesini G, Brizi M, Morselli-Labate A, Bianchi G, Bugianesi E, McCullough AJ: Association of nonalcoholic fatty liver disease with insulin resistance. Am J of Medicine 1999; 107: 450-454
29. Sanyal AJ, Campbell Sargent C, Mirshashi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA: Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001; 120: 1183-1192
30. Rashid M, Roberts EA: Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr 2000; 30: 48-53.
31. Chitturi S, Abeygunasekera S, Farrell G, Holmes-Walker J: NASH and insulin resistance : insulin hypersecretion and specific association with the insulin resistance syndrome. Hepatology 2002; 73: 373-378
32. Pagano C, Soardoo g, Esposito W, Fallo F, Basan L, Donnini D, Federspil G. Plasma adiponectin is decreased in nonalcoholic fatty liver disease. Eur J of endocrinology 2005; 152: 113-118
33. Shklyaev S, Aslanidi G, Tennant M, Prima V, Kohlbrenner E, Kroutov V. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc Natl Acad Sci USA 2003; 100: 14217-14222